| Not Yet Recruiting | A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | 2026-02-28 |
| Not Yet Recruiting | A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma Moderate to Severe Asthma | Phase 3 | 2026-01-26 |
| Recruiting | The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesi Overweight or Obesity | Phase 1 | 2025-02-27 |
| Completed | Semaglutide in Treatment of Obesity Weight Management | Phase 3 | 2024-09-20 |
| Completed | A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 3 | 2024-04-15 |
| Completed | A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 3 | 2024-04-08 |
| Completed | A Study of TG103 Injection in the Management of Non-diabetic Overweight or Obesity Obesity, Overweight | Phase 2 | 2024-02-21 |
| Completed | A Study of TG103 Injection in Non-diabetic Overweight or Obesity Overweight or Obesity | Phase 3 | 2023-11-22 |
| Unknown | A Study of TG103 Injection in Type 2 Diabetes Subjects Type 2 Diabetes Mellitus | Phase 2 | 2022-06-15 |
| Unknown | A Study of TG103 Injection in Overweight or Obesity Overweight or Obesity | Phase 2 | 2022-05-20 |
| Unknown | A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 2 | 2021-10-01 |
| Unknown | Study to Evaluate the Therapeutic Equivalence of SYN008 Versus Xolair® in the Treatment of Patients With Refra Chronic Spontaneous Urticaria | Phase 3 | 2021-07-01 |
| Completed | A Study of TG103 Injection in Overweight/Obese Subjects Without Diabetes Diabetes | Phase 1 | 2021-07-01 |
| Completed | A Comparative Study of TG103 Produced by Two Manufacturing Processes in Chinese Healthy Male Subjects Healthy Male Subjects | Phase 1 | 2021-05-18 |
| Unknown | Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic Syndrome Hemophagocytic Syndrome | N/A | 2020-08-01 |
| Unknown | Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Maligna Lymphoma, Leukemia | N/A | 2020-08-01 |
| Unknown | Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of A Advanced Pancreatic Cancer | N/A | 2020-02-01 |
| Unknown | Evaluation of the Application of PEGylated Recombinant Human Granulocyte Stimulating Factor Injection (PEG-rhG Elderly Lymphoma Patients | N/A | 2019-02-22 |
| Unknown | Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia Chemotherapy-induced Neutropenia, Myelosuppression | — | 2019-02-13 |
| Unknown | Evaluate the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia After Chemotherapy in Patients With Non Hodgkin's Lymphoma | N/A | 2019-01-01 |
| Unknown | PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving Chemotherapy Small Cell Lung Cancer, PEG-rhG-CSF | N/A | 2018-12-05 |
| Completed | PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy Lymphoma | Phase 4 | 2013-09-01 |
| Completed | PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy Breast Cancer | Phase 4 | 2013-04-01 |
| Completed | PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy Malignant Solid Tumors | Phase 4 | 2013-04-01 |
| Completed | PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia Breast Cancer | Phase 4 | 2013-04-01 |